Vol 31, No 1 (2024)
Review Article
Published online: 2023-05-26

open access

Page views 1131
Article views/downloads 821
Get Citation

Connect on Social Media

Connect on Social Media

Atrioventricular synchronous leadless pacing: Micra AV

Bruno Hrymniak1, Przemysław Skoczyński12, Bartosz Biel1, Waldemar Banasiak1, Dariusz Jagielski1
Pubmed: 37246458
Cardiol J 2024;31(1):147-155.

Abstract

Since the arrival of leadless pacemakers (LPs), they have become a cornerstone in remedial treatment of bradycardia and atrioventricular (AV) conduction disorders, as an alternative to transvenous pacemakers. Even though clinical trials and case reports show indisputable benefits of LP therapy, they also bring some doubts. Together with the positive results of the MARVEL trials, AV synchronization has become widely available in LPs, presenting a significant development in leadless technology. This review presents the Micra AV (MAV), describes major clinical trials, and introduces the basics of AV synchronicity obtained with the MAV and its unique programming options.

Article available in PDF format

View PDF Download PDF file

References

  1. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35): 3427–3520.
  2. Reddy VY, Knops RE, Sperzel J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014; 129(14): 1466–1471.
  3. Chinitz L, Ritter P, Khelae SK, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies. Heart Rhythm. 2018; 15(9): 1363–1371.
  4. Steinwender C, Khelae SK, Garweg C, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. JACC Clin Electrophysiol. 2020; 6(1): 94–106.
  5. Omdahl P, Eggen MD, Bonner MD, et al. Right ventricular anatomy can accommodate multiple Micra transcatheter pacemakers. Pacing Clin Electrophysiol. 2016; 39(4): 393–397.
  6. Saleem-Talib S, van Driel VJ, Nikolic T, et al. The jugular approach for leadless pacing: A novel and safe alternative. Pacing Clin Electrophysiol. 2022; 45(10): 1248–1254.
  7. Contractor T, Co ML, Cooper J. Is there a way to confirm true septal placement of leadless pacemakers? Proposal of the "RAO space" sign. Pacing Clin Electrophysiol. 2021; 44(1): 176–177.
  8. Kaczmarek K, Cygankiewicz I, Czarniak B, et al. Septal implantation of the Micra transcatheter pacing system guided by intraprocedural transesophageal echocardiography. Kardiol Pol. 2019; 77(12): 1190–1192.
  9. Kiani S, Wallace K, Stromberg K, et al. A predictive model for the long-term electrical performance of a leadless transcatheter pacemaker. JACC Clin Electrophysiol. 2021; 7(4): 502–512.
  10. Hrymniak B, Biel B, Szwarc B, et al. Implantation of a leadless pacemaker in a patient with an atrioventricular block and COVID-19. Kardiol Pol. 2021; 79(11): 1294–1295.
  11. Kempa M, Mitkowski P, Kowalski O, et al. Expert opinion of a Working Group on Leadless Pacing appointed by the National Consultant in Cardiology and the Board of the Heart Rhythm Section of the Polish Cardiac Society. Kardiol Pol. 2021; 79(5): 604–608.
  12. Briongos-Figuero S, Estévez-Paniagua Á, Sánchez Hernández A, et al. Optimizing atrial sensing parameters in leadless pacemakers: Atrioventricular synchrony achievement in the real world. Heart Rhythm. 2022; 19(12): 2011–2018.
  13. Chinitz LA, El-Chami MF, Sagi V, et al. Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study. Heart Rhythm. 2023; 20(1): 46–54.
  14. Sagi V, Sheldon T, Cornell S. B-PO04-209 achieving optimal ambulatory performance with an AV synchronous leadless pacemaker during high sinus rates: a case report. Heart Rhythm. 2021; 18(8): S364.
  15. Burkman G, Saltsburg M, Buck M, et al. Leadless pacemaker-induced torsades de pointes. HeartRhythm Case Rep. 2021; 7(2): 79–82.
  16. Udo EO, Zuithoff NPA, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012; 9(5): 728–735.
  17. Reynolds D, Duray GZ, Omar R, et al. Micra Transcatheter Pacing Study Group. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016; 374(6): 533–541.
  18. Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017; 14(9): 1375–1379.
  19. Cantillon DJ, Exner DV, Badie N, et al. Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment. JACC Clin Electrophysiol. 2017; 3(11): 1296–1305.
  20. El-Chami MF, Bockstedt L, Longacre C, et al. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up. Eur Heart J. 2022; 43(12): 1207–1215.
  21. Piccini JP, Cunnane R, Steffel J, et al. Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022; 24(7): 1119–1126.
  22. Minami K, Shtëmbari J, Petrů J, et al. Successful retrieval of a 4-year-old micra transcatheter pacemaker system in a patient with leadless biventricular pacing therapy. JACC Case Rep. 2020; 2(14): 2249–2252.
  23. Mechulan A, Prevot S, Peret A, et al. Micra AV leadless pacemaker implantation after transcatheter aortic valve implantation. Pacing Clin Electrophysiol. 2022; 45(11): 1310–1315.
  24. El-Chami MF, Shinn T, Bansal S, et al. Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker. J Cardiovasc Electrophysiol. 2021; 32(3): 832–841.
  25. Turagam MK, Gopinathannair R, Park PH, et al. Safety and efficacy of leadless pacemaker for cardioinhibitory vasovagal syncope. Heart Rhythm. 2020; 17(9): 1575–1581.
  26. Omdahl P, Eggen MD, Bonner MD, et al. Right ventricular anatomy can accommodate multiple Micra transcatheter pacemakers. Pacing Clin Electrophysiol. 2016; 39(4): 393–397.
  27. Kempa M, Mitkowski P, Kowalski O, et al. Expert opinion of a Working Group on Leadless Pacing appointed by the National Consultant in Cardiology and the Board of the Heart Rhythm Section of the Polish Cardiac Society. Kardiol Pol. 2021; 79(5): 604–608.
  28. MicraTM AV MC1AVR1 MR Conditional Dual Chamber Transcatheter Pacing System with SureScanTM Technology (VDD) Device Manual.
  29. Rate Smoothing for Micra AV. https://www.medtronicacademy.com/features/rate-smoothing-micra-av.
  30. Tracking Check for Micra AV. https://www.medtronicacademy.com/features/tracking-check-micra-av.
  31. El-Chami MF, Bhatia NK, Merchant FM. Atrio-ventricular synchronous pacing with a single chamber leadless pacemaker: Programming and trouble shooting for common clinical scenarios. J Cardiovasc Electrophysiol. 2021; 32(2): 533–539.